Rare diseases
Investigational molecules
Locations
Back to France606 clinical trials in Saint-Herblain, France across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Long-term Study of Sotatercept for Adults with Pulmonary Arterial Hypertension (PAH)
FranceStudy of Nivolumab and Relatlimab for Adults with Advanced or Metastatic Soft-Tissue Sarcoma
FranceStudy on the Effect of Low-Dose Aspirin in Preventing New or Recurrent Colorectal Polyps in Patients with Lynch Syndrome
FranceStudy of Berubicin versus Lomustine in adult patients with recurrent Glioblastoma Multiforme after first-line treatment failure
FranceStudy of Cemiplimab and Chemotherapy Combination for Patients with Advanced Non-Small Cell Lung Cancer
FranceStudy on the Effectiveness and Safety of BAY 2927088 Compared to Standard Treatment in Patients with Advanced Non-Small Cell Lung Cancer with HER2 Mutations
FranceFranceStudy on Advanced Soft-Tissue Sarcoma: Testing Futibatinib and Drug Combination for Patients with Unresectable or Metastatic Conditions
FranceStudy of Zanidatamab and Tislelizumab Combined with Chemotherapy for Patients with Advanced or Metastatic HER2-positive Gastroesophageal Cancer
FranceStudy on Atezolizumab for Patients with Locally Advanced Cervical Cancer
FranceStudy of Elraglusib Alone or with Chemotherapy for Patients with Refractory Blood Cancers or Solid Tumors
FranceA Study of Cabazitaxel and Pelvic Radiation Therapy Combined with Hormone Treatment for Patients with High-Risk Localized Prostate Cancer
FranceThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on advanced cancer treatments, including studies for breast cancer, lung cancer, and gastric cancer. Research includes novel therapeutic approaches targeting specific cancer types.
Several trials are evaluating new antibody-drug conjugates and combination therapies for metastatic diseases.
Studies targeting various neurological conditions, with emphasis on frontotemporal dementia and multiple sclerosis. Research focuses on innovative therapeutic approaches and disease-modifying treatments.
Trials include evaluation of novel antibodies and assessment of long-term treatment efficacy.
Comprehensive research into heart failure prevention, pulmonary hypertension, and cardiac rhythm disorders. Studies focus on innovative therapeutic approaches and preventive measures.
Research includes long-term safety assessments and combination therapy evaluations.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
